Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. alpharoyalpharmacy.com
WARNING LETTER
•alpharoyalpharmacy.com•September 2, 2020

alpharoyalpharmacy.com – FDA Warning Letter, Sep 2, 2020

Record Details

On September 2, 2020, the FDA issued a Warning Letter to www.alpharoyalpharmacy.com for offering unapproved new drugs and misbranded opioids for sale to U.S. consumers, violating sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the FD&C Act. The FDA highlighted the public health crisis of opioid addiction and the risks of unapproved drugs, which lack safety and effectiveness assurances and may be contaminated or counterfeit.

Specifically, the website offered "tramadol 225 mg tablets manufactured by Royal Inc," claiming it treats moderate to severe pain. This product is an unapproved new drug under section 201(p) and 505(a) of the FD&C Act, as no FDA-approved applications are in effect for it. FDA-approved tramadol carries a "black box warning" due to risks like addiction, abuse, respiratory depression, and neonatal opioid withdrawal syndrome.

Furthermore, the tramadol product is misbranded under section 502(f)(1) because it lacks adequate directions for use by a layperson, as it is a prescription drug requiring professional supervision. The website also offered tramadol without requiring a prescription, violating section 503(b)(1) and 301(k) of the FD

Company
alpharoyalpharmacy.com
Inspection date
September 2, 2020
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Donald D. Ashley (Director)
View Company Profile

ID · f730b91e-9685-43c1-b4f1-ab627823ebdc

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 331(a)21 U.S.C. 331(d)21 U.S.C. 331(k)21 U.S.C. 353(b)21.U.S.C. 355(a)21 U.S.C. 321(p)21 U.S.C. 352(f)(1)21 U.S.C. 353(b)(1)(A)21 CFR 201.5

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore alpharoyalpharmacy.com
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.